PANC
Showing 1 - 25 of 118
Advances in Imaging to Assess Response in Pancreatic Cancer
Recruiting
- Pancreatic Ductal Adenocarcinoma
-
Glasgow, United KingdomBeatson West of Scotland Cancer Centre
Feb 3, 2023
Pancreatic Cancer Non-resectable Trial (collection of blood and tumor samples)
Not yet recruiting
- Pancreatic Cancer Non-resectable
- collection of blood and tumor samples
- (no location specified)
Mar 27, 2023
Determining Individualized Cancer Therapy in Pancreatic Cancer
Not yet recruiting
- Pancreatic Neoplasms
- Targeted Therapy
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
Jun 14, 2023
Metastatic Pancreatic Adenocarcinoma Trial in Baltimore (Epacadostat, Pembrolizumab, CRS-207)
Active, not recruiting
- Metastatic Pancreatic Adenocarcinoma
- Epacadostat
- +4 more
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 3, 2023
Pancreatic Cancer Trial in Baltimore (Cyclophosphamide, GVAX, Pembrolizumab)
Active, not recruiting
- Pancreatic Cancer
- Cyclophosphamide
- +3 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Jan 5, 2023
Pancreatic Cyst, Pancreatic Tumors, Pancreatic Cancer Trial in San Francisco (Survey)
Recruiting
- Pancreatic Cyst
- +7 more
- Survey
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 20, 2022
Panc CA Risk Model & Biomarker Testing In High-Risk Cohort
Not yet recruiting
- Pancreatic Adenocarcinoma
- Blood Specimen
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Sep 5, 2022
Pancreatic Cancer Trial in United States (Niraparib Treatment)
Recruiting
- Pancreatic Cancer
- Niraparib Treatment
-
Fairway, Kansas
- +5 more
May 17, 2022
Cancer Cachexia in Subjects With Panc Adenocarcinoma
Recruiting
- Pancreas Adenocarcinoma
- Cachexia
-
Charlotte, North CarolinaLevine Cancer Institute
Jun 17, 2022
Pancreatic Cancer Trial in Baltimore (PANC 10.05 pcDNA-1/GM-Neo and PANC 6.03 pcDNA-1 neo vaccine.)
Recruiting
- Pancreatic Cancer
- PANC 10.05 pcDNA-1/GM-Neo and PANC 6.03 pcDNA-1 neo vaccine.
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 3, 2022
Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Circulating Tumor Cell Trial in Montpellier (Detection of
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +2 more
- Detection of circulating tumor cells expressing Axl: CTC-AXL(+)
-
Montpellier, FranceCHU Montpellier
Jul 1, 2022
Pancreatic Cancer Trial in Baltimore, Milwaukee (Cyclophosphamide, Nivolumab, GVAX Pancreas Vaccine)
Active, not recruiting
- Pancreatic Cancer
- Cyclophosphamide
- +3 more
-
Baltimore, Maryland
- +1 more
Mar 3, 2022
Pancreatic Cancer Trial in Baltimore (drug, biological, radiation)
Active, not recruiting
- Pancreatic Cancer
- Cyclophosphamide
- +3 more
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 3, 2022
Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC), Pancreatic Ductal Adenocarcinoma Trial in Baltimore (Stereotactic Body
Recruiting
- Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
- Pancreatic Ductal Adenocarcinoma
- Stereotactic Body Radiation (SBRT)
- +3 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Jan 28, 2022
Resected Pancreatic Adenocarcinoma Trial in Washington (mFOLFIRINOX, Proton beam radiation)
Recruiting
- Resected Pancreatic Adenocarcinoma
- mFOLFIRINOX
- Proton beam radiation
-
Washington, District of ColumbiaGeorgetown University Medical Center - Lombardi Comprehensive Ca
Jul 27, 2021
Cardiopulmonary Exercise Testing: An Assessment of Patients
Not yet recruiting
- Pancreatic Cancer
- Cardiopulmonary Exercise Test
- (no location specified)
Jan 4, 2021
Previously Treated Metastatic Adenocarcinoma of the Pancreas Trial in United States (CRS-207, nivolumab, GVAX)
Completed
- Previously Treated Metastatic Adenocarcinoma of the Pancreas
- CRS-207
- +3 more
-
San Francisco, California
- +4 more
Mar 17, 2021
Metastatic Pancreatic Adenocarcinoma Trial in San Francisco, Baltimore, Saint Louis (Ipilimumab, Vaccine, FOLFIRINOX)
Completed
- Metastatic Pancreatic Adenocarcinoma
- Ipilimumab
- +2 more
-
San Francisco, California
- +2 more
May 5, 2020
Pancreatic Cancer Trial in Baltimore (Cetuximab, Pancreatic tumor vaccine, Cyclophosphamide)
Completed
- Pancreatic Cancer
- Cetuximab
- +2 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 10, 2020
Pancreatic Cancer Trial in Baltimore (Ipilimumab, Pancreatic Cancer Vaccine)
Completed
- Pancreatic Cancer
- Ipilimumab
- Pancreatic Cancer Vaccine
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 20, 2020
Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +19 more
- A2B694
- xT CDx with HLA-LOH Assay
-
Duarte, California
- +9 more
Sep 22, 2023
Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +15 more
- A2B530
- xT-Onco with HLA-LOH Assay
-
Duarte, California
- +6 more
Feb 10, 2023
Predict Lymphovascular Invasion in Pancreatic Ductal
Recruiting
- Predictive Cancer Model
- Pancreas Cancer
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Aug 10, 2023
PDAC - Pancreatic Ductal Adenocarcinoma Trial in Verona (Register)
Recruiting
- PDAC - Pancreatic Ductal Adenocarcinoma
- Register
-
Verona, ItalyAOUI Verona
May 3, 2023